Expression of Lymphocyte Differentiation Antigens in Immunodeficiency Diseases

  • Thomas F. Tedder
  • Loran T. Clement
  • Marilyn J. Crain
  • Max D. Cooper
Conference paper

Abstract

Immunodeficiency diseases are frequently caused by defects in lymphocyte differentiation resulting in inadequate synthesis of immunoglobulin (Ig) or the lack of antigen-specific antibodies (1). The failure of B cells to differentiate into plasma cells results from either inherent B cell defects, the selective absence of helper T cell activity, excessive suppressor T cell activity, or Epstein—Barr virus infection (2,3). The most common deficiency is the failure of IgA production. Patients with selective IgA deficiency (IgA-) have B cells of normal phenotypes except their IgA B cells are immature and coexpress surface IgM (4). In addition, these patients may be concomitantly deficient in other IgG isotypes (5). Patients with common variable immunodeficiency (CVI) have normal numbers of B and T cells of normal phenotypes, but few if any plasma cells (6). Similarly, X-linked immunodeficiency (XLA; X-linked agammaglobulinemia) results from abortive B cell differentiation. Males with this disease form normal numbers of bone marrow pre—B cells, but are deficient in B cells and plasma cells (7). The frequency of circulating B cells is 100-fold lower than that in normals, but the T cell lineage appears to be unaffected since cell-mediated immunity is intact and circulating T cells and T cell subsets are normal in number, proportion, and function. Patients with acquired immunodeficiency disease syndrome (AIDS) have a preferential loss of helper T cells that results in suppression of T cell function (8).

Keywords

Pneumonia Myeloma Fluorescein FITC Rosen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosen, F. S., M. D. Cooper and R. J. P. Wedgwood. 1984. The primary immunodeficiencies. New England J. Med. 311: 235.CrossRefGoogle Scholar
  2. 2.
    Siegal, F. P., M. Siegal and R. A. Good. 1978. Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. New England J. Med. 299: 172.CrossRefGoogle Scholar
  3. 3.
    Reinherz, E. L., M. D. Cooper, S. F. Schlossman and F. S. Rosen. 1981. Abnormalities of T cell maturation and regulation in human beings with immuno-deficiency disorders. J. Clin. Invest. 68: 699.PubMedCrossRefGoogle Scholar
  4. 4.
    Conley, M. E. and M. D. Cooper. 1981. Immature IgA cells in IgA deficient patients. New England J. Med. 305: 495.CrossRefGoogle Scholar
  5. 5.
    Oxelius, V-A., A-B. Laurell, B. Lindquist, H. Golebiowska, V. Axelsson, J. Bjorkander and L. A. Hanson. 1981. IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. New England J. Med. 304: 1476.CrossRefGoogle Scholar
  6. 6.
    Preud’homme, J. L., C. Friscelli and M. Seligmann. 1973. Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency disease. Clin. Immunol. Immunopathol. 1: 241.PubMedCrossRefGoogle Scholar
  7. 7.
    Pearl, E. R., L. B. Vogler, A. J. Okos, W. M. Crist, A. R. Lawton and M. D. Cooper. 1978. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J. Immunol. 120: 1169.PubMedGoogle Scholar
  8. 8.
    Gottleib, M. S., R. Schroff, H. M. Schanker, J. D. Weisman, P. T. Fan, R. A. Wolf and A. Saxon. 1981. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. New England J. Med. 305: 1425.CrossRefGoogle Scholar
  9. 9.
    Lane, H.C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. New England J. Med. 309: 453.CrossRefGoogle Scholar
  10. 10.
    Tedder, T. F., L. T. Clement and M. D. Cooper. 1983. Use of monoclonal antibodies to examine differentiation antigens on human B cells. Fed. Proc. 42: 415A.Google Scholar
  11. 11.
    Tedder, T. F., L. T. Clement and M. D. Cooper. 1984. Expression of C3d receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133: 678.PubMedGoogle Scholar
  12. 12.
    Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, J. A. Barbosa and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81: 4510.PubMedCrossRefGoogle Scholar
  13. 13.
    Tedder, T. F., L. T. Clement and M. D. Cooper. 1984. Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation. Tissue Antigens 24: 140.PubMedCrossRefGoogle Scholar
  14. 14.
    Tedder, T. F., M. D. Cooper, and L. T. Clement. 1984. Differential production of B cell growth and differentiation factors by phenotypically distinct subpopulations of human helper T cells. Fed. Proc. 43: 1826A.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • Thomas F. Tedder
  • Loran T. Clement
  • Marilyn J. Crain
  • Max D. Cooper

There are no affiliations available

Personalised recommendations